ID: ALA2048035

Max Phase: Preclinical

Molecular Formula: C28H23Cl2N3O6S

Molecular Weight: 600.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[S+]([O-])c1cncc(CC(NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)O)c1

Standard InChI:  InChI=1S/C28H23Cl2N3O6S/c1-40(38)19-8-15(12-31-13-19)9-22(28(36)37)32-26(34)24-21(29)10-18-14-33(6-4-20(18)25(24)30)27(35)17-3-2-16-5-7-39-23(16)11-17/h2-3,5,7-8,10-13,22H,4,6,9,14H2,1H3,(H,32,34)(H,36,37)

Standard InChI Key:  CMVMPRRSIRJGRR-UHFFFAOYSA-N

Associated Targets(Human)

Intercellular adhesion molecule (ICAM-1), Integrin alpha-L/beta-2 760 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver microsomes 16955 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver microsomes 8692 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 600.48Molecular Weight (Monoisotopic): 599.0685AlogP: 4.50#Rotatable Bonds: 7
Polar Surface Area: 135.80Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.23CX Basic pKa: 1.78CX LogP: 2.46CX LogD: -0.75
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.30Np Likeness Score: -0.43

References

1. Zhong M, Gadek TR, Bui M, Shen W, Burnier J, Barr KJ, Hanan EJ, Oslob JD, Yu CH, Zhu J, Arkin MR, Evanchik MJ, Flanagan WM, Hoch U, Hyde J, Prabhu S, Silverman JA, Wright J..  (2012)  Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye.,  (3): [PMID:24900456] [10.1021/ml2002482]

Source